Significant Ownership of GREAT POINT PARTNERS LLC

Notable people
M.D. Dr. Jeffrey R. Jay, Mr. David Kroin, Ortav Yehudai, Lillian Nordahl
Signature - Title
/s/ Dr. Jeffrey R. Jay, M.D - Dr. Jeffrey R. Jay, M.D - Senior Managing Member
Location
Greenwich, CT
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by GREAT POINT PARTNERS LLC.

Notify me when GREAT POINT PARTNERS LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of GREAT POINT PARTNERS LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
UNCY Unicycive Therapeutics, Inc. Common Stock, par value $0.001 per share 10% $7,228,095 11,473,166 Great Point Partners, LLC 31 Dec 2024
PMN ProMIS Neurosciences Inc. Common Shares, no par value per share 10% $2,790,563 409,648 Great Point Partners, LLC 31 Dec 2025
PMN ProMIS Neurosciences Inc. Common Shares, no par value per share 10% $2,547,215 +$1,125,043 5,972,369 +79% Great Point Partners, LLC 30 Sep 2025
ZURA Zura Bio Ltd Class A Ordinary Shares 5.2% $19,995,473 3,815,930 0% Great Point Partners, LLC 31 Dec 2025
CNTX Context Therapeutics Inc. Common Stock 5.1% $6,885,055 4,683,711 0% Great Point Partners, LLC 31 Dec 2025
OTLK Outlook Therapeutics, Inc. Common Stock, $0.001 par value per share 5% $4,484,400 2,220,000 0% Great Point Partners, LLC 30 Jun 2025
VTGN Vistagen Therapeutics, Inc. Common Stock, $0.001 par value per share 5% $1,521,317 2,055,834 0% Great Point Partners, LLC 31 Dec 2025
OPTN OPTINOSE, INC. Common Stock, $0.001 par value per share 4.9% $4,789,466 -$3,369,457 526,315 -41% Great Point Partners, LLC 31 Mar 2025
UNCY Unicycive Therapeutics, Inc. Common Stock, par value $0.001 per share 4.5% $3,472,993 796,558 0% Great Point Partners, LLC 30 Sep 2025
Inventiva S.A. Ordinary shares, nominal value 0.01 Euro per share 3.5% 6,783,269 -21% Great Point Partners, LLC 31 Dec 2025
VOR VOR BIOPHARMA INC. Common Stock, $0.0001 par value per share 3.3% $18,578,651 +$1,839,021 1,370,107 +11% Great Point Partners, LLC 31 Dec 2025
NGNE NEUROGENE INC. Common Stock, par value $0.000001 per share 3% $6,822,947 442,761 Great Point Partners, LLC 31 Dec 2024

Schedules 13D/G Reported by GREAT POINT PARTNERS LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.